Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:vadadustat
|
| gptkbp:approvalYear |
2023
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
B03XA14
|
| gptkbp:form |
film-coated tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vikarby
|
| gptkbp:indication |
anemia due to chronic kidney disease
|
| gptkbp:marketingAuthorizationHolder |
gptkb:Otsuka_Pharmaceutical
|
| gptkbp:mechanismOfAction |
HIF-PH inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Rättvik_Municipality
|
| gptkbp:bfsLayer |
6
|